Vaccine Market – Future Scope Detailed Analysis to 2023

Vaccine Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Vaccine Market by type(DNA vaccines, conjugate, live attenuated, inactivated, toxoid, and subunit), by application(allergy, autism, cancer and infectious diseases) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Vaccine Market it includes the five years Industry analysis and the 6 years annual forecast from 2017 to 2023. Some of the prominent participants in the Global Vaccine Market are  Mitsubishi Tanabe, AstraZeneca, Merck & Co. Inc, GlaxoSmithKline plc (GSK), Pfizer Inc., SANOFI S.A, NOVARTIS AG, Takeda Pharmaceuticals, Astellas Pharma Inc., and Emergent BioSolutions. According to the report the Global Vaccine Market is projected to grow at a CAGR of 11% in terms of value over the period of 2017-2023.

Vaccine also referred to as human vaccine, as defined by WHO, is a biological preparation that improves immunity to a particular disease. It contains an agent that resembles a disease causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Human body has natural ability to learn about eliminating all sorts of germs or microbes that cause diseases. Vaccine utilizes that ability of the body to enable it to protect itself, from those microbes, which have attacked it before. Typically, vaccines are administered through injections, orally and sprayed into the nose. Human vaccines are of two types such as preventable and therapeutic vaccines. According to report the global vaccine market was sized over USD 29.17 billion in 2016. The global vaccine market is projected to grow with a CAGR 5.2% in terms of value during the forecast period, 2017-2023 and reach USD 41.87 billion by 2023.

The Government Support for the Development of Vaccines is Likely to Augment the Growth in the Market over the Next Six Years

 High prevalence of infectious diseases is the primary factor driving the growth in the global market for vaccines. Moreover, the government support for the development of vaccines is likely to augment the growth in the market over the next six years. Moreover, and increasing investments in the research and development of new vaccines is expected to accelerate the growth in the vaccine market over the forecast period. On the other hand, high cost associated with development of vaccines is the primary restraining factor hampering the growth in the market over the forecast period. Government initiatives in emerging markets and economic development in emerging markets of Asia, Latin America and Africa to augment the healthcare expenditure per capita and new vaccines in pipeline are likely to provide opportunities for the companies operating in the global vaccines market.

Segments Covered

The report on global vaccine market covers segments such as type and application. The type segments include conjugate, recombinant, inactivated, combination, attenuated and others. On the basis of application, the global vaccine market is categorized into infectious disease, cancer, allergy, and others.

U.S. Drives the Growth in the North America Region as it is the Largest Market in the Region

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.The countries covered in the North America region include the U.S., Canada and Mexico; while Asia-Pacific includes China, Japan, India, South Korea and Malaysia among others. Moreover, The European region covers countries such as, Germany, UK, France, Spain and Rest of Europe. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017 – 2023.

Companies Profiled:

The report provides profiles of the companies in the global vaccine market such as, Mitsubishi Tanabe, AstraZeneca, Merck & Co. Inc, GlaxoSmithKline plc (GSK), Pfizer Inc., SANOFI S.A, NOVARTIS AG, Takeda Pharmaceuticals, AstellasPharma Inc. and Emergent BioSolutions.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the Global Vaccine Market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of vaccine market. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the Vaccine Market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the vaccine market to understand the present and future trends in this market and formulate their strategies accordingly.

Table of Contents:-

1. Preface

1.1 Report Description

1.2 Research Methods

1.3 Research Approaches

2. Executive Summary

3. Global Vaccine Market Overview

3.1 Introduction

3.2 Market Dynamics

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunities

3.3 Porter’s Five Forces Analysis

3.4 IGR – Growth Matrix Analysis

3.5 Competitive Landscape in the Global Vaccine Market

4. Global Vaccine Market by Type 2017 – 2023

4.1 Conjugate

4.2 Recombinant

4.3 Inactivated

4.4 Combination

4.5 Attenuated

4.6 Others

5. Global Vaccine Market by Application 2017 – 2023

5.1 Infectious Disease

5.2 Cancer

5.3 Allergy

5.4 Others

6. Global Vaccine Market by Regions 2017 – 2023

6.1 North America

6.1.1 North America Vaccine Market by Type

6.1.2 North America Vaccine Market by Application

6.1.3 North America Vaccine Market by Country6.2 Europe

6.2.1 Europe Vaccine Market by Type

6.2.2 Europe Vaccine Market by Application

6.2.3 Europe Vaccine Market by Country

6.3 Asia-Pacific

6.3.1 Asia-Pacific Vaccine Market by Type

6.3.2 Asia-Pacific Vaccine Market by Application

6.3.3 Asia-Pacific Vaccine Market by Country

6.4 RoW

6.4.1 RoW Vaccine Market by Type

6.4.2 RoW Vaccine Market by Application

6.4.3 RoW Vaccine Market by Sub-region

7. Companies Covered

7.1 Mitsubishi Tanabe

7.2 AstraZeneca

7.3 Merck & Co. Inc

7.4 GlaxoSmithKline plc (GSK)

7.5 Pfizer Inc.



7.8 Takeda Pharmaceuticals

7.9 Astellas Pharma Inc.

7.10 Emergent BioSolutions

Browse Detailed TOC, Description and Companies Mentioned in Report @

Reset Password